Role of 68GA-DOTATOC pet/ct in therapeutic decision-making for well-differentiated neuroendocrine tumours

#4370

Introduction: 68Ga-DOTATOC PET/CT is a highly sensitive and specific test for assessing gastroenteropancreatic and pulmonary neuroendocrine tumours (NET) expressing somatostatin receptors.

Aim(s): To evaluate the role of 68Ga-DOTATOC PET/CT in therapeutic decision-making for patients with NET.

Materials and methods: This retrospective study evaluated patients with pathology-confirmed NET who underwent 68Ga-DOTATOC PET/CT between December 2021 and August 2024 at two tertiary care centres. A total of 48 patients were identified; 11 were excluded due to the absence of a confirmed diagnosis. Electronic medical records were reviewed to collect clinicopathological and imaging data.

Conference:

Presenting Author: Cruz-Diaz W

Authors: Cruz Diaz W, Landaeta Kancev L, Martinez-Amores Martínez B, Bastidas Tamayo J, Estrella Santos A,

Keywords: 68Ga-DOTATOC PET/CT, well-differentiated, gastroenteropancreatic, pulmonary, neuroendocrine tumour, Lu-177-DOTATATE,